Showing results (101-110 of 191) with videos related to
Sort By:
Pageof 20
Biorxiv : the Preprint Server for Biology|May 27, 2024
Excitoprotective effects of conditional tau reduction in excitatory neurons and in adulthoodYuliya Voskobiynyk, Zhiyong Li, J Nicholas Cochran, et al.Eneuro|March 27, 2026
Parvalbumin Neuron-Targeted Loss of Alzheimer's Disease Risk Gene <i>BIN1</i> Is Insufficient to Drive Cognitive or Network Excitability ChangesM Natalie Davis, Mary Bullock, Aanishaa Jhaldiyal, et al.Elife|July 14, 2020
Alzheimer's disease risk gene <i>BIN1</i> induces Tau-dependent network hyperexcitabilityYuliya Voskobiynyk, Jonathan R Roth, J Nicholas Cochran, et al.Journal of Chromatography. A|May 11, 2026
Quantification of residual protein from biocatalysts employed in the synthesis of pharmaceutical drug substances using reversed-phase HPLCMatthew R Swoyer, Kaitlyn M Flynn, Timothy A Brown, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 13, 2026
Cholecalciferol (vitamin D3) is an agonist of the Alzheimer's disease-associated immune receptor TREM2Hunter B Dean, Ryan A Tuckey, Rory A Greer, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 14, 2011
Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's diseaseErik D Roberson, Brian Halabisky, Jong W Yoo, et al.Neurology|September 15, 2005
Frontotemporal dementia progresses to death faster than Alzheimer diseaseE D Roberson, J H Hesse, K D Rose, et al.Neurobiology of Aging|October 30, 2016
Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's diseaseMarissa Natelson Love, David G Clark, J Nicholas Cochran, et al.Plos Genetics|January 7, 2021
Aberrant regulation of a poison exon caused by a non-coding variant in a mouse model of Scn1a-associated epileptic encephalopathyYuliya Voskobiynyk, Gopal Battu, Stephanie A Felker, et al.Science Translational Medicine|April 27, 2022
TAU ablation in excitatory neurons and postnatal TAU knockdown reduce epilepsy, SUDEP, and autism behaviors in a Dravet syndrome modelEric Shao, Che-Wei Chang, Zhiyong Li, et al.Pageof 20